.png)
Relationship Between Clinical Factors of Lymphoma DLBCL GCB and Non-GCB Subtype with Ki-67 Proliferation Index in Siloam Karawaci Hospital 2014 - 2018
Abstract
Background: Non-Hodgkin large cell B-lymphoma (DLBCL: Diffuse Large B-cell Lymphoma) were classified into two subtypes of Germinal Center B-Cell Like (GCB) and non-Germinal Center B-Cell Like (non-GCB), which GCB has a better prognosis. The Ki-67 antigen is one of the most reliable markers of cell proliferation. This research aims to establish the relationship between proliferation index Ki-67 with DLBCL subtypes and to evaluate the utility of Ki-67 proliferative index as a predictive marker for predicting stages of lymphoma.
Methods: We obtained 60 cases of patient samples DLBCL in Siloam Hospital Lippo Karawaci in 2014-2018. Clinical and pathological data were obtained from medical records. Chi-square methods were used to analyze data.
Result: There were more ≤60 years compared to >60 years. In this study, there were more male patients than female patients. lymphoma provided in extranodal were higher than lymphoma in nodal form.
Conclusions: There is a relationship between Ki-67 proliferation index with lymphoma GCB and non-GCB subtypes and stage of lymphoma, which can be used as a predictive factor in predicting the stage of lymphoma.
Keywords
DOI: http://dx.doi.org/10.19166/med.v11i1.7365
Full Text:
PDFReferences
1. Jaffe ES. The 2008 WHO Classification of Lymphomas: Implication For Clinical Practice and Translational Research. American Society Of Hematology 2009;(1):523-531. https://doi.org/10.1182/asheducation-2009.1.523
2. Bakta IM. Hematologi Klinis Ringkas. Jakarta: EGC 2006; h.192-219
3. Reksodiputro H, Irawan C, Harjolukito E, Suzana E, et al. Non-Hodgkin Lymphoma in Jakarta. Indonesian Journal of Cancer 2011;5(3):129-133. http://dx.doi.org/10.33371/ijoc.v5i3.171
4. Jaffe ES. The 2008 WHO Classification of Lymphomas: Implication For Clinical Practice and Translational Research. American Society Of Hematology 2009;523-531. https://doi.org/10.1182/asheducation-2009.1.523
5. Tang YL, Zhou Y, Cheng LL, Su YZ, Wang C Bin. BCL2/Ki-67 index predict survival in germinal center B-cell-like diffuse large B-cell lymphoma. Oncol Lett. 2017;14(3):3767–73. https://doi.org/10.3892/ol.2017.6577
6. Mozaheb, Zahra. Epidemiology of Lymphoid Malignancy in Asia, Epidemiology Insight, Dr. Maria De Lourdes Ribeiro De Souza Da Cunha (ed.). InTech. 2012. https://doi.org/10.5772/31746
7. Yasmin Bhurgri et al.2005.Increasing Incidence of Non-Hodgkin’s Lymphoma in Karachi 1995-2002.Asian Pacific J Cancer Prev. 2005;6(3): 364-369. https://www.researchgate.net/deref/http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpubmed%2F16236001
8. Mengko SK., Surarso B. Patogenesis Limfoma Non-Hodgkin Extra Nodal Kepala dan. J tht-kl. 2009;2(1):32–47.
9. Youssef M.I, Maghraby H, Youssef E.A, El-Sayed M.M. Expression of Ki 67 in hepatocellular carcinoma induced by diethylnitrosamine in mice and its correlation with histopathological alterations. Journal of Applied Pharmaceutical Science 2012. 2(3): 52-59. http://dx.doi.org/10.7324/JAPS.2012.2309
10. Kramer, E, Herman, O, Frand J, Leibou L, Schreiber L, Vaknine H.2014. Ki67 as Biologic Marker of Basal Cell Carcinoma: A Retrospective Study. IMAJ. 2014;16(4): 229-232. https://www.researchgate.net/deref/http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpubmed%2F24834759
Refbacks
- There are currently no refbacks.
Copyright (c) 2023 Erna Kristiani, Stephanie Marisca, Tri Ulfatul Qurro, Natasya Kweeswara, Amos Immanuel Chandra
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
MEDICINUS is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. Copyright © Fakultas Kedokteran | Universitas Pelita Harapan | Lippo Karawaci, Tangerang, Indonesia, 15811 . All rights reserved. p-ISSN 1978-3094 | e-ISSN 2622-6995